Research shows potential for emergence of new Ebola virus that causes disease in humans

March 24, 2016
The Ebola virus, isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells in a BSL-4 suite at Rocky Mountain Laboratories. Credit: NIAID

New research at the University of Kent has highlighted the potential for the emergence of a new form of Ebolavirus.

A team from the University's School of Biosciences examined the differences between Ebolaviruses that cause severe in humans and the Reston that does not.

The Reston virus, which is known to circulate in domestic pigs in Asia and occasionally infect humans, is currently the only member of the Ebolavirus family not to have been reported as causing life-threatening disease in humans.

Using computational analysis of the sequences of the genomes of Ebolaviruses and a computational prediction of the effects of sequence variations on virus function, the researchers, Dr Mark Wass, Senior Lecturer in Computational Biology, Professor Martin Michaelis, Professor of Molecular Medicine, and Dr Jeremy Rossman, Lecturer in Virology, and their teams, identified characteristic differences in a number of virus proteins.

The results suggested that only a few changes in one Ebolavirus protein, VP24, may be necessary to render the Reston virus into a virus that can cause human disease. There may be a risk therefore that Reston viruses acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat.

The research, entitled Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses, is published in Scientific Reports.

Explore further: Study finds pigs susceptible to virulent ebolavirus can transmit the virus to other animals

More information: Morena Pappalardo et al. Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses, Scientific Reports (2016). DOI: 10.1038/srep23743

Related Stories

Study finds a weak spot on deadly ebolavirus

November 21, 2011

Scientists from The Scripps Research Institute and the US Army's Medical Research Institute of Infectious Diseases have isolated and analyzed an antibody that neutralizes Sudan virus, a major species of ebolavirus and one ...

New cancer treatment hope for children

December 7, 2015

Children suffering from a cancer of the nervous system could benefit from a potential new treatment, thanks to an international team led by researchers at the University of Kent and at the Institute of Medical Virology at ...

Recommended for you

$460-mn vaccine push to 'outsmart' viruses

January 19, 2017

With the world still reeling from outbreaks of deadly Ebola and baby-deforming Zika, governments and charities launched a $460-million (431 million-euro) initiative Thursday to "outsmart" infectious epidemics.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.